Corbus Pharmaceuticals
CRBP
CRBP
82 hedge funds and large institutions have $27.3M invested in Corbus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less call options, than puts
Call options by funds: $290K | Put options by funds: $332K
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
40% less capital invested
Capital invested by funds: $45.6M → $27.3M (-$18.4M)
Holders
82
Holding in Top 10
1
Calls
$290K
Puts
$332K
Top Buyers
| 1 | +$519K | |
| 2 | +$188K | |
| 3 | +$151K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$112K |
| 5 |
D.E. Shaw & Co
New York
|
+$86.8K |
Top Sellers
| 1 | -$362K | |
| 2 | -$179K | |
| 3 | -$164K | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$160K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$117K |